ethyl pyruvate has been researched along with Pneumonia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, SM; Charavaryamath, C; Karriker, LA; Massey, N; Singh, B | 1 |
| de Vos, AF; Draing, C; Larosa, GJ; van der Poll, T; van Zoelen, MA; von Aulock, S | 1 |
| Fukumoto, J; Hamada, N; Kawaguchi, T; Kuwano, K; Maeyama, T; Nakanishi, Y; Yamada, M; Yamada, S; Yoshimi, M | 1 |
3 other study(ies) available for ethyl pyruvate and Pneumonia
| Article | Year |
|---|---|
Ethyl pyruvate reduces organic dust-induced airway inflammation by targeting HMGB1-RAGE signaling.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line; Cytokines; Dust; HMGB1 Protein; Humans; Immunohistochemistry; Pneumonia; Pyruvates; Rats; Receptor for Advanced Glycation End Products; Respiratory Tract Diseases; Signal Transduction; Swine | 2019 |
Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Line; Dose-Response Relationship, Drug; Epithelial Cells; Female; Flavoring Agents; Lipopolysaccharides; Macrophages, Alveolar; Mice; Pneumonia; Pyruvates; Teichoic Acids; Tumor Necrosis Factor-alpha | 2007 |
The role of high mobility group box1 in pulmonary fibrosis.
Topics: Animals; Antibodies; Apoptosis; Bleomycin; Bronchi; Bronchoalveolar Lavage Fluid; Cell Proliferation; Collagen; Epithelial Cells; Fibroblasts; HMGB1 Protein; Humans; Lung; Lung Diseases, Interstitial; Male; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Pyruvates | 2008 |